Afternoon Symposium - Oncofertility II - Female
Time:4:15 pm - 6:15 pm
Location:HCC316 - Hawaii Convention Center
Mitchell P. Rosen, M.D. (Chair), University of California San Francisco Center for Reproductive Health
Kutluk Oktay, M.D., New York Medical College
Janine Mash, M.S., University of California, San Francisco
Richard A. Anderson, M.D., Ph.D., University of Edinburgh
Supported by an educational grant from Ferring Pharmaceuticals, Inc.
Needs Assessment and Description
Many young adult women diagnosed with cancer will
have treatment that can reduce reproductive lifespan,
although many don’t learn this fact before their treatment
commences. Yet, obtaining information about the risk of
treatment-associated infertility and premature menopause
is a top concern for patients. Our understanding of how
cancer treatment affects ovarian reserve and how we
manage patients undergoing fertility preservation continues
to evolve. This symposium will provide reproductive
endocrinologists and oncologists with the most current
information on how to counsel and individualize the
potential loss in reproductive capacity. Faculty will also
discuss current treatments for fertility preservation and
focus on additional factors that should be considered when
caring for these patients.
At the conclusion of this session, participants should be
- Counsel patients regarding the risk of gonadal failure
after cancer treatments.
- Describe how to optimally manage/stimulate patients
undergoing fertility preservation.
- Determine a plan for patients with inherited
conditions who may desire preimplantation genetic
Interpersonal and Communication Skills
Which of the following would be least accurate when
managing cancer patients who are considering fertility
a. An assessment of ovarian reserve is required at the
b. Patients must wait until their menses begin to start
ovarian stimulation for the purpose of egg/embryo
c. Genetic evaluation is required to determine the genetic
predisposition of their disease.
d. If menses resume after chemotherapy, early menopause
is inversely associated with the age of the patient.